ginkgolide b has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brochet, B; Confavreux, C; Guinot, P; Lavergne, V; Orgogozo, JM; Rumbach, L | 1 |
| Brochet, B; Dartigues, JF; Guinot, P; Henry, P; Loiseau, P; Orgogozo, JM | 1 |
2 trial(s) available for ginkgolide b and Multiple Sclerosis
| Article | Year |
|---|---|
Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis.
Topics: Activities of Daily Living; Acute Disease; Adult; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Lactones; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence; Severity of Illness Index; Treatment Outcome | 1995 |
[Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis].
Topics: Adult; Diterpenes; Female; Ginkgolides; Humans; Lactones; Male; Multiple Sclerosis; Neurologic Examination; Pilot Projects; Platelet Activating Factor | 1992 |